Loading data
CRDONasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.34 bn USD | 436.78 m USD | 192.97 m USD | 184.19 m USD | 106.48 m USD |
| Cost of revenue | 426.77 m USD | 153.87 m USD | 73.54 m USD | 78 m USD | 42.46 m USD |
| Gross profit | 908.35 m USD | 282.91 m USD | 119.43 m USD | 106.19 m USD | 64.02 m USD |
| Research and development expense | 279.38 m USD | 146.87 m USD | 96.3 m USD | 76.77 m USD | 47.95 m USD |
| Selling, general and administrative expense | 183.96 m USD | 98.92 m USD | 60.19 m USD | 48.25 m USD | 34.9 m USD |
| Operating profit | 445.01 m USD | 37.12 m USD | -37.06 m USD | -21.24 m USD | -21.97 m USD |
| Profit before tax | 475.44 m USD | 54.87 m USD | -22.75 m USD | -17.91 m USD | -22.21 m USD |
| Income tax expense | 3.16 m USD | 2.69 m USD | 5.62 m USD | -1.37 m USD | -37 k USD |
| Net income (reported basis) | 472.28 m USD | 52.18 m USD | -28.37 m USD | -16.55 m USD | -22.18 m USD |
| Basic earnings per share | 2.65 USD/share | 0.31 USD/share | -0.18 USD/share | -0.11 USD/share | -0.25 USD/share |
| Diluted earnings per share | 2.51 USD/share | 0.29 USD/share | -0.18 USD/share | -0.11 USD/share | -0.25 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.